U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 12097

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr17:27274843-30817038
GRCh38:
Chr17:28947825-32490020
See casesPathogenic
(Dec 10, 2012)
no assertion criteria provided
2.
GRCh37:
Chr17:28952286-30386515
GRCh38:
Chr17:30625268-32059496
See casesPathogenic
(Aug 26, 2013)
no assertion criteria provided
3.
GRCh37:
Chr17:28957752-30415399
GRCh38:
Chr17:30630734-32088380
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
4.
GRCh38:
Chr17:30660608-31159168
Neurofibromatosis, type 1Pathogenicno assertion criteria provided
5.
GRCh37:
Chr17:28993036-30412788
GRCh38:
Chr17:30666018-32085769
See casesPathogenic
(Aug 1, 2014)
no assertion criteria provided
6.
GRCh37:
Chr17:28994990-30350877
GRCh38:
Chr17:30667972-32023858
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
7.
GRCh37:
Chr17:28999834-30326958
GRCh38:
Chr17:30672816-31999939
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
8.
GRCh37:
Chr17:29004621-30398720
GRCh38:
Chr17:30677603-32071701
See casesUncertain significance
(Feb 14, 2018)
no assertion criteria provided
9.
GRCh37:
Chr17:29005171-30400885
GRCh38:
Chr17:30678153-32073866
See casesPathogenic
(Mar 11, 2013)
no assertion criteria provided
10.
GRCh37:
Chr17:29011937-30348421
GRCh38:
Chr17:30684919-32021402
See casesPathogenic
(Apr 30, 2011)
no assertion criteria provided
11.
GRCh37:
Chr17:29033863-30326952
GRCh38:
Chr17:30706845-31999933
See casesPathogenic
(Sep 21, 2012)
no assertion criteria provided
12.
GRCh37:
Chr17:29033881-30321643
GRCh38:
Chr17:30706863-31994624
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
13.
GRCh37:
Chr17:29033882-30326958
GRCh38:
Chr17:30706864-31999939
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
14.
GRCh37:
Chr17:29033882-30426780
GRCh38:
Chr17:30706864-32099761
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
15.
GRCh37:
Chr17:29033882-30326958
GRCh38:
Chr17:30706864-31999939
See casesUncertain significance
(Feb 14, 2018)
no assertion criteria provided
16.
GRCh37:
Chr17:29094212-30264505
GRCh38:
Chr17:30767194-31937486
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
17.
GRCh37:
Chr17:29158338-29649192
GRCh38:
Chr17:30831320-31322174
See casesUncertain significance
(Mar 10, 2014)
no assertion criteria provided
18.
GRCh37:
Chr17:29421945-29509683
GRCh38:
Chr17:31094927-31182665
LOC111811965, LOC108281169, LOC108281170, LOC108281180, NF1Neurofibromatosis, type 1Uncertain significance
(Oct 1, 2016)
criteria provided, single submitter
19.
GRCh37:
Chr17:29421945-29509683
GRCh38:
Chr17:31094927-31182665
LOC108281180, LOC111811965, LOC108281169, LOC108281170, NF1Neurofibromatosis, type 1Pathogenic
(Dec 16, 2016)
criteria provided, single submitter
20.
GRCh37:
Chr17:29421945-29422387
GRCh38:
Chr17:31094927-31095369
LOC111811965, NF1Neurofibromatosis, type 1Pathogenic
(Jan 3, 2017)
criteria provided, single submitter
21.
GRCh37:
Chr17:29421945-29422387
GRCh38:
Chr17:31094927-31095369
NF1, LOC111811965Neurofibromatosis, type 1Uncertain significance
(Jan 10, 2017)
criteria provided, single submitter
22.
GRCh37:
Chr17:29421945-29704695
GRCh38:
Chr17:31094927-31377677
Neurofibromatosis, type 1Pathogenic
(Nov 27, 2019)
criteria provided, single submitter
23.
GRCh37:
Chr17:29421965
GRCh38:
Chr17:31094947
LOC111811965, NF1Neurofibromatosis, type 1, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal,
Neurofibromatosis-Noonan syndrome
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
24.
GRCh37:
Chr17:29422006
GRCh38:
Chr17:31094988
LOC111811965, NF1Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal,
Café-au-lait macules with pulmonary stenosis
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
25.
GRCh37:
Chr17:29422039-29422055
GRCh38:
Chr17:31095021-31095037
LOC111811965, NF1Neurofibromatosis, type 1Uncertain significance
(Aug 27, 2021)
criteria provided, single submitter
26.
GRCh37:
Chr17:29422055
GRCh38:
Chr17:31095037
LOC111811965, NF1Neurofibromatosis, type 1Uncertain significance
(Dec 16, 2021)
criteria provided, single submitter
27.
GRCh37:
Chr17:29422055
GRCh38:
Chr17:31095037
LOC111811965, NF1Neurofibromatosis, type 1Uncertain significance
(Sep 29, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr17:29422056
GRCh38:
Chr17:31095038
LOC111811965, NF1Neurofibromatosis, type 1Pathogenic
(Jun 27, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr17:29422056
GRCh38:
Chr17:31095038
LOC111811965, NF1not provided, Neurofibromatosis, type 1Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
30.
GRCh37:
Chr17:29422063
GRCh38:
Chr17:31095045
LOC111811965, NF1Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal,
Neurofibromatosis, type 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
31.
GRCh37:
Chr17:29422076-29422077
GRCh38:
Chr17:31095058-31095059
LOC111811965, NF1Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal,
Café-au-lait macules with pulmonary stenosis
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
32.
GRCh37:
Chr17:29422076-29422077
GRCh38:
Chr17:31095058-31095059
NF1, LOC111811965Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal,
Café-au-lait macules with pulmonary stenosis
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
33.
GRCh37:
Chr17:29422077
GRCh38:
Chr17:31095059
LOC111811965, NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
34.
GRCh37:
Chr17:29422082-29422083
GRCh38:
Chr17:31095064-31095065
NF1, LOC111811965Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal,
Café-au-lait macules with pulmonary stenosis
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
35.
GRCh37:
Chr17:29422087-29422088
GRCh38:
Chr17:31095069-31095070
LOC111811965, NF1Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal,
Café-au-lait macules with pulmonary stenosis
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
36.
GRCh37:
Chr17:29422091
GRCh38:
Chr17:31095073
NF1, LOC111811965Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal,
Café-au-lait macules with pulmonary stenosis
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
37.
GRCh37:
Chr17:29422099
GRCh38:
Chr17:31095081
LOC111811965, NF1Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal,
Café-au-lait macules with pulmonary stenosis
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
38.
GRCh37:
Chr17:29422119
GRCh38:
Chr17:31095101
NF1, LOC111811965Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal,
Café-au-lait macules with pulmonary stenosis
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
39.
GRCh37:
Chr17:29422155
GRCh38:
Chr17:31095137
LOC111811965, NF1Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal,
Café-au-lait macules with pulmonary stenosis
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
40.
GRCh37:
Chr17:29422162
GRCh38:
Chr17:31095144
LOC111811965, NF1Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome,
Neurofibromatosis, familial spinal
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
41.
GRCh37:
Chr17:29422180
GRCh38:
Chr17:31095162
LOC111811965, NF1Neurofibromatosis, type 1, Juvenile myelomonocytic leukemia, Neurofibromatosis-Noonan syndrome,
Neurofibromatosis, familial spinal, Neurofibromatosis, type 1, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis
Uncertain significance
(Oct 27, 2021)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr17:29422213
GRCh38:
Chr17:31095195
LOC111811965, NF1Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal,
Café-au-lait macules with pulmonary stenosis
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
43.
GRCh37:
Chr17:29422244
GRCh38:
Chr17:31095226
NF1, LOC111811965Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal,
Café-au-lait macules with pulmonary stenosis
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
44.
GRCh37:
Chr17:29422255
GRCh38:
Chr17:31095237
NF1, LOC111811965Neurofibromatosis-Noonan syndrome, Neurofibromatosis, type 1, Neurofibromatosis, familial spinal,
Café-au-lait macules with pulmonary stenosis
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
45.
GRCh37:
Chr17:29422277
GRCh38:
Chr17:31095259
LOC111811965, NF1Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal,
Neurofibromatosis, type 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
46.
GRCh37:
Chr17:29422278-29701241
GRCh38:
Chr17:31095260-31374223
Neurofibromatosis, type 1Pathogenic
(Feb 6, 2018)
criteria provided, single submitter
47.
GRCh37:
Chr17:29422306
GRCh38:
Chr17:31095288
NF1, LOC111811965not specified, not provided, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, type 1
Benign/Likely benign
(Oct 1, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr17:29422310
GRCh38:
Chr17:31095292
LOC111811965, NF1Hereditary cancer-predisposing syndromeLikely benign
(Oct 27, 2020)
criteria provided, single submitter
49.
GRCh37:
Chr17:29422318-29422397
GRCh38:
Chr17:31095300-31095379
LOC111811965, NF1Neurofibromatosis, type 1Pathogenic
(Dec 18, 2018)
criteria provided, single submitter
50.
GRCh37:
Chr17:29422318-29422397
GRCh38:
Chr17:31095300-31095379
LOC111811965, NF1Neurofibromatosis, type 1Uncertain significance
(Jun 13, 2019)
criteria provided, single submitter
51.
GRCh37:
Chr17:29422318-29701183
GRCh38:
Chr17:31095300-31374165
Neurofibromatosis, type 1Uncertain significance
(Jul 9, 2019)
criteria provided, single submitter
52.
GRCh37:
Chr17:29422318-29701183
GRCh38:
Chr17:31095300-31374165
Neurofibromatosis, type 1Pathogenic
(Jul 16, 2019)
criteria provided, single submitter
53.
GRCh37:
Chr17:29422320
GRCh38:
Chr17:31095302
LOC111811965, NF1Neurofibromatosis, type 1Uncertain significance
(Aug 26, 2015)
criteria provided, single submitter
54.
GRCh37:
Chr17:29422322-29701179
GRCh38:
Chr17:31095304-31374161
Neurofibromatosis, type 1Pathogenic
(Nov 6, 2019)
criteria provided, single submitter
55.
GRCh37:
Chr17:29422322-29701179
GRCh38:
Chr17:31095304-31374161
Neurofibromatosis, type 1Uncertain significance
(Sep 19, 2017)
criteria provided, single submitter
56.
GRCh37:
Chr17:29422322-29483150
GRCh38:
Chr17:31095304-31156132
LOC111811965, NF1, LOC108281169Neurofibromatosis, type 1Pathogenic
(Oct 10, 2017)
criteria provided, single submitter
57.
GRCh37:
Chr17:29422324
GRCh38:
Chr17:31095306
LOC111811965, NF1Cardiovascular phenotype, Hereditary cancer-predisposing syndromeUncertain significance
(Mar 10, 2021)
criteria provided, single submitter
58.
GRCh37:
Chr17:29422325-29422329
GRCh38:
Chr17:31095307-31095311
LOC111811965, NF1M1fsCardiovascular phenotype, Hereditary cancer-predisposing syndromePathogenic
(Jun 29, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr17:29422326
GRCh38:
Chr17:31095308
LOC111811965, NF1Cardiovascular phenotype, Hereditary cancer-predisposing syndromeUncertain significance
(Oct 8, 2018)
criteria provided, single submitter
60.
GRCh37:
Chr17:29422326
GRCh38:
Chr17:31095308
LOC111811965, NF1Hereditary cancer-predisposing syndromeUncertain significance
(May 8, 2015)
criteria provided, single submitter
61.
GRCh37:
Chr17:29422328
GRCh38:
Chr17:31095310
LOC111811965, NF1M1LCardiovascular phenotype, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1
Pathogenic
(Oct 21, 2021)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr17:29422328
GRCh38:
Chr17:31095310
NF1, LOC111811965M1LNeurofibromatosis, type 1Likely pathogeniccriteria provided, single submitter
63.
GRCh37:
Chr17:29422328
GRCh38:
Chr17:31095310
NF1, LOC111811965M1VCardiovascular phenotype, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1,
not provided
Pathogenic
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr17:29422329
GRCh38:
Chr17:31095311
LOC111811965, NF1M1KCardiovascular phenotype, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1,
not provided
Pathogenic/Likely pathogenic
(Mar 15, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr17:29422329
GRCh38:
Chr17:31095311
LOC111811965, NF1M1Rnot provided, Neurofibromatosis, type 1, Hereditary cancer-predisposing syndrome,
Cardiovascular phenotype
Pathogenic
(Sep 6, 2022)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr17:29422329
GRCh38:
Chr17:31095311
LOC111811965, NF1M1Tnot provided, Cardiovascular phenotype, Hereditary cancer-predisposing syndrome,
Neurofibromatosis, type 1
Pathogenic
(Oct 12, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr17:29422330
GRCh38:
Chr17:31095312
LOC111811965, NF1M1ICardiovascular phenotype, Hereditary cancer-predisposing syndromePathogenic
(Feb 14, 2019)
criteria provided, single submitter
68.
GRCh37:
Chr17:29422330
GRCh38:
Chr17:31095312
LOC111811965, NF1M1INeurofibromatosis, type 1, Cardiovascular phenotype, Hereditary cancer-predisposing syndrome
Pathogenic
(Feb 10, 2022)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr17:29422331
GRCh38:
Chr17:31095313
LOC111811965, NF1A2SCardiovascular phenotype, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1
Uncertain significance
(Feb 22, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr17:29422331-29422332
GRCh38:
Chr17:31095313-31095314
LOC111811965, NF1A2FCardiovascular phenotype, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1
Uncertain significance
(Jul 13, 2022)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr17:29422332
GRCh38:
Chr17:31095314
LOC111811965, NF1A2DNeurofibromatosis, type 1Uncertain significance
(Dec 27, 2021)
criteria provided, single submitter
72.
GRCh37:
Chr17:29422332
GRCh38:
Chr17:31095314
LOC111811965, NF1A3fsNeurofibromatosis, type 1Pathogenic
(Oct 11, 2020)
criteria provided, single submitter
73.
GRCh37:
Chr17:29422332
GRCh38:
Chr17:31095314
LOC111811965, NF1A2VHereditary cancer-predisposing syndromeUncertain significance
(Jan 12, 2016)
criteria provided, single submitter
74.
GRCh37:
Chr17:29422333
GRCh38:
Chr17:31095315
LOC111811965, NF1Neurofibromatosis, type 1, Hereditary cancer-predisposing syndrome, Cardiovascular phenotype
Likely benign
(Sep 6, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr17:29422333
GRCh38:
Chr17:31095315
LOC111811965, NF1Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1, not provided
Likely benign
(Mar 15, 2022)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr17:29422334
GRCh38:
Chr17:31095316
LOC111811965, NF1A3TCardiovascular phenotype, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1
Uncertain significance
(Feb 18, 2022)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr17:29422335
GRCh38:
Chr17:31095317
LOC111811965, NF1A3ECardiovascular phenotype, Hereditary cancer-predisposing syndromeUncertain significance
(Oct 5, 2021)
criteria provided, single submitter
78.
GRCh37:
Chr17:29422335
GRCh38:
Chr17:31095317
LOC111811965, NF1A3GNeurofibromatosis, type 1Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
79.
GRCh37:
Chr17:29422335
GRCh38:
Chr17:31095317
LOC111811965, NF1A3VHereditary cancer-predisposing syndrome, Cardiovascular phenotype, Neurofibromatosis, type 1
Uncertain significance
(Dec 29, 2021)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr17:29422336
GRCh38:
Chr17:31095318
LOC111811965, NF1Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1
Likely benign
(Apr 30, 2021)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr17:29422336
GRCh38:
Chr17:31095318
LOC111811965, NF1H4fsNeurofibromatosis, type 1Pathogenic
(Nov 25, 2020)
criteria provided, single submitter
82.
GRCh37:
Chr17:29422337
GRCh38:
Chr17:31095319
NF1, LOC111811965H4fsNeurofibromatosis, type 1Pathogenic
(Jan 15, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr17:29422337
GRCh38:
Chr17:31095319
LOC111811965, NF1H4YNeurofibromatosis, type 1Uncertain significance
(Sep 29, 2021)
criteria provided, single submitter
84.
GRCh37:
Chr17:29422337
GRCh38:
Chr17:31095319
LOC111811965, NF1H4NNeurofibromatosis, type 1Uncertain significance
(Aug 20, 2021)
criteria provided, single submitter
85.
GRCh37:
Chr17:29422339
GRCh38:
Chr17:31095321
LOC111811965, NF1Cardiovascular phenotype, Hereditary cancer-predisposing syndromeLikely benign
(Mar 8, 2021)
criteria provided, single submitter
86.
GRCh37:
Chr17:29422340
GRCh38:
Chr17:31095322
LOC111811965, NF1Cardiovascular phenotype, Hereditary cancer-predisposing syndromeLikely benign
(Nov 4, 2021)
criteria provided, single submitter
87.
GRCh37:
Chr17:29422340
GRCh38:
Chr17:31095322
LOC111811965, NF1R5GHereditary cancer-predisposing syndrome, Cardiovascular phenotype, Neurofibromatosis, type 1
Uncertain significance
(Aug 30, 2021)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr17:29422340
GRCh38:
Chr17:31095322
LOC111811965, NF1R5WCardiovascular phenotype, Hereditary cancer-predisposing syndromeUncertain significance
(Sep 4, 2019)
criteria provided, single submitter
89.
GRCh37:
Chr17:29422341
GRCh38:
Chr17:31095323
LOC111811965, NF1R5fsNeurofibromatosis, type 1Pathogenic
(Jan 15, 2020)
criteria provided, single submitter
90.
GRCh37:
Chr17:29422342
GRCh38:
Chr17:31095324
NF1, LOC111811965Neurofibromatosis, type 1Likely benign
(Mar 29, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr17:29422342
GRCh38:
Chr17:31095324
LOC111811965, NF1R5SNeurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1
Uncertain significance
(Apr 12, 2022)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr17:29422343
GRCh38:
Chr17:31095325
NF1, LOC111811965P6Snot providedUncertain significance
(Apr 18, 2018)
criteria provided, single submitter
93.
GRCh37:
Chr17:29422344
GRCh38:
Chr17:31095326
LOC111811965, NF1P6QCardiovascular phenotype, Hereditary cancer-predisposing syndromeUncertain significance
(Feb 19, 2020)
criteria provided, single submitter
94.
GRCh37:
Chr17:29422344
GRCh38:
Chr17:31095326
NF1, LOC111811965P6Rnot provided, Hereditary cancer-predisposing syndrome, Cardiovascular phenotype,
Neurofibromatosis, type 1
Uncertain significance
(Jul 11, 2022)
criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr17:29422344
GRCh38:
Chr17:31095326
LOC111811965, NF1P6LJuvenile myelomonocytic leukemia, Neurofibromatosis, familial spinal, Neurofibromatosis, type 1,
Café-au-lait macules with pulmonary stenosis, Neurofibromatosis-Noonan syndrome, Cardiovascular phenotype,
Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1
Uncertain significance
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr17:29422346
GRCh38:
Chr17:31095328
LOC111811965, NF1V7MNeurofibromatosis, type 1Uncertain significance
(Aug 28, 2021)
criteria provided, single submitter
97.
GRCh37:
Chr17:29422347-29422350
GRCh38:
Chr17:31095329-31095332
LOC111811965, NF1V7fsNeurofibromatosis, type 1Pathogenic
(Feb 16, 2021)
criteria provided, single submitter
98.
GRCh37:
Chr17:29422349-29422350
GRCh38:
Chr17:31095331-31095332
LOC111811965, NF1E8fsNeurofibromatosis, type 1Pathogenic
(Aug 16, 2021)
criteria provided, single submitter
99.
GRCh37:
Chr17:29422353-29422359
GRCh38:
Chr17:31095335-31095341
LOC111811965, NF1V10fsCardiovascular phenotype, Hereditary cancer-predisposing syndromePathogenic
(Aug 20, 2020)
criteria provided, single submitter
100.
GRCh37:
Chr17:29422353
GRCh38:
Chr17:31095335
LOC111811965, NF1W9LNeurofibromatosis, type 1Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination